News

News from The American Academy of Ophthalmology

• Patterns of Ellipsoid Zone Loss May Predict Progression in MacTel
  A longitudinal OCT imaging study identified three distinct patterns of ellipsoid zone loss in macular telangiectasia type 2 (MacTel) corresponding with different rates of disease progression.
• Weekly Journal Update — February 18, 2026
  Emergency department imaging protocol for triaging visual symptoms, prefilled syringes and endophthalmitis rates, GLP-1 RAs and sight-threatening diabetic retinopathy, lactic acid as a uveal melanoma marker, drugs associated with cataracts in children.
• Recommendations for Standardizing Uveitic Glaucoma Management Are Proposed
  This article summarizes proposed recommendations for the management of uveitic glaucoma formulated by The Uveitic Glaucoma Interest Group (UGIG), a worldwide group of uveitis and glaucoma specialists with expertise in this condition.
• In Patients With Obesity, Sleep Apnea May Increase the Risk of Ptosis and Dermatochalasis
  A retrospective cohort study was conducted to assess the risk of eyelid ptosis and dermatochalasis in patients with obesity and obstructive sleep apnea vs matched controls.
• Ocular Adverse Events From Antibody-Drug Conjugates Could Indicate a Survival Benefit
  A large database study found that having ocular side effects from antibody-drug conjugate (ADC) cancer treatments was associated with significantly better odds of survival.
• Week in Review: Ergonomics Training for Residents, NAION Risk With Semaglutide Use in a Veteran Population
  Training residents early in proper ergonomics for performing slit lamp exams can reduce musculoskeletal strain later, and the diabetes drug semaglutide is linked with a greater risk of nonarteritic anterior ischemic optic neuropathy (NAION) in a group of US veterans.
• Crosslinking Under General Anesthesia Shows Efficacy in Patients With Down Syndrome
  A retrospective analysis found epithelium-off corneal collagen crosslinking performed under general anesthesia to be relatively safe and effective for managing keratoconus in patients with Down syndrome.
• New Innovations Target the Glaucoma Treatment Gap
  At the Glaucoma 360 2026 New Horizons Forum, the “Devices Changing the Eye Game” symposium showcased a variety of innovations aimed at bridging the gap between minimally invasive glaucoma surgery (MIGS) and traditional filtration surgery.
• Weekly Journal Update — February 11, 2026
  Adalimumab vs immunosuppressive drugs for uveitis, retinal vascular occlusions and dementia, the gut microbiome and AMD, regenerative cell therapy for corneal edema, systemic drugs and maculopathy.
• Asymmetric Multipoint Defocus Technique Lenses Show Promise in Reducing Myopia Progression
  In a Chinese population, asymmetric multipoint defocus technique (AMDT) spectacle lenses, which have higher magnitudes and larger surface areas of myopic defocus than single-vision lenses (SVLs), helped to slow myopia progression to a greater extent than SVLs.